Convergent Genomics

Convergent Genomics, a lab spin-off from Oregon Health & Science University, was founded in 2015 and subsequently entered the Illumina Accelerator program, spending six months refining its early detection process. The mission of Convergent Genomics is to simplify and accelerate cancer diagnosis, providing clinicians and patients with personalized data and actionable insights. Using advanced liquid biopsy technology and next-generation sequencing, we can extract DNA from urine to identify cancer risks at the genetic level earlier.